Fig. 4From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysisForest plot of hazard ratio of progression-free survival using a random-effects model of hepatocellular carcinomaBack to article page